Extent of Field Change in Colorectal Cancers with BRAF Mutation

Total Page:16

File Type:pdf, Size:1020Kb

Extent of Field Change in Colorectal Cancers with BRAF Mutation Singapore Med J 2018; 59(3): 139-143 Original Article https://doi.org/10.11622/smedj.2017012 Extent of field change in colorectal cancers with BRAF mutation Aaron Poh1, FRCS, Heidi Sian Ying Chang2, MRCS, Kok Yang Tan1, FRCS, Xin Xiu Sam3, BSc(Hons), Avery Khoo3, BSc, Shoa Nian Choo4, BSc, Min En Nga4, FRCPath, Wei Keat Wan5, FRCPath INTRODUCTION Sporadic colorectal cancers with BRAF mutations constitute two distinct subgroups of colorectal cancers. Recent studies have linked the presence of the BRAF mutation to a familial inheritance pattern. This was a proof- of-concept study that aimed to examine: (a) the extent of field change in sporadic colorectal cancers with BRAF mutation; and (b) the extent of resection margins required and the pattern of DNA mismatch repair protein loss in these tumours. METHODS Eight microsatellite instability-high tumours with positive BRAF mutation from an existing histopathological database were selected for BRAF mutation and mismatch repair protein analysis. RESULTS All the resection margins were negative for BRAF mutation. Three tumours had loss of MLH1 and PMS2 expressions, and five tumours had no protein loss. Six peritumoral tissues were negative and one was positive for BRAF mutation. CONCLUSION The results suggest that any early field change effect is restricted to the immediate vicinity of the tumour and is not a pan-colonic phenomenon. Current guidelines on resection margins are adequate for BRAF mutation-positive colorectal cancers. Any suggestion of a hereditary link to these tumours is likely not related to germline BRAF gene mutations. The pattern of protein loss reinforces previous findings for the two subgroups of BRAF mutation-positive colorectal cancers. Keywords: BRAF mutation, colorectal cancer INTRODUCTION partial methylation of the MLH1 gene, presence of BRAF Colorectal cancers can be divided into several groups based mutation, and stable microsatellite instability (MSS) or low levels on their molecular characteristics. These characteristics are of microsatellite instability (MSI-L). Tumours in the second group underpinned by different pathways of tumorigenesis (Table I). are also chromosomally stable and make up 8% of colorectal The earliest known pathways are the chromosomal instability cancers.(1-8) The two subgroups of colorectal cancers share some (familial adenomatous polyposis [FAP]) and DNA mismatch repair common characteristics, namely the presence of BRAF mutation, (MMR) (hereditary non-polyposis colorectal cancer [HNPCC]) high levels of CIMP methylation, an element of MLH1 gene pathways.(1-3) The serrated pathway was subsequently noted after methylation (either partial or full) and an element of microsatellite the observation that a subgroup of hyperplastic polyps behaved in instability (MSI-L or MSI-H).(1-8) a manner similar to adenomatous polyps, resulting in an analysis Microsatellite instability is also seen in a third subgroup of serrated polyps and their associated pathway.(1) of colorectal cancers, namely in HNPCC or Lynch syndrome. Further work on the classification of colorectal cancers In contrast to the above two subgroups, HNPCC tumours are focused on additional molecular characteristics for further hereditary in nature but do not have BRAF mutations, are CIMP- delineation. Jass(2) hypothesised in 2007 that there are five separate negative and always show MSI-H. HNPCC is characterised by subgroups of colorectal cancers based on multiple molecular germline mutations in the genes that encode DNA MMR proteins. characteristics. Sporadic colorectal cancers with BRAF mutations More than 90% of these mutations occur in the genes encoding constitute two separate subgroups out of the five possible for MLH1 and MutS homolog 2 (MSH2), with the remainder subgroups of colorectal cancers according to this classification. occurring in the MSH6 and PMS1 homolog 2 (PMS2) genes. Due These two subgroups were the focus of our study. to the inherent germline mutations present, there is a generalised The first subgroup is made up of colorectal cancers field change, and the entire colon and rectum are at risk for characterised by high levels of DNA methylation at CpG islands development of tumours.(1,2,9) (CIMP-high), methylation of the MutL homolog 1 (MLH1) gene, The group of BRAF mutation-positive colorectal cancers presence of BRAF mutation and high levels of microsatellite was the subject of the present study. The presence of BRAF instability (MSI-H). These are chromosomally stable tumours mutation in the presence of MSI-H status has been touted as a and make up 12% of colorectal cancers.(3-8) The second subgroup negative predictor for germline MMR mutations and a possible is made up of colorectal cancers characterised by CIMP-high, exclusion criterion for germline testing. However, some recent 1Department of General Surgery, Khoo Teck Puat Hospital, 2University Surgical Cluster, National University Hospital, 3Histopathology Translational Research Group, Department of Pathology, Singapore General Hospital, 4Department of Pathology, National University Hospital, 5Department of Pathology, Singapore General Hospital, Singapore Correspondence: Dr Chang Sian Ying Heidi, Resident, University Surgical Cluster, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074. [email protected] 139 Original Article Table I. Classification of colorectal cancers based on molecular characteristics. Characteristic Chromosomal instability (FAP) Mismatch repair (HNPCC) Serrated pathway Hybrid pathway pathway pathway Heredity Sporadic and hereditary (FAP Hereditary only (HNPCC Sporadic and hereditary Sporadic only syndrome) syndrome) MSI status MSS MSI-H MSI-H MSI-L MSS or MSI-L Chromosomal Present Absent Absent Absent Present instability BRAF mutation No No Yes Yes No KRAS mutation Yes Yes/No No No Yes CIMP status Negative Negative High High Low MLH1 status Normal Mutated Methylated Partial methylation Normal CIMP: CpG island methylator phenotype; FAP: familial adenomatous polyposis; HNPCC: hereditary non-polyposis colorectal cancer; KRAS: V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; MLH1: MutL homolog 1; MSI: microsatellite instability; MSI-H: microsatellite instability-high; MSI-L: microsatellite instability-low; MSS: microsatellite stable population-based studies have suggested a familial tendency METHODS for colorectal cancers with BRAF mutation or CIMP-high status, This was a retrospective study. Colorectal tumours from an suggesting a possible new cancer family syndrome.(10-12) There is existing histopathological database were filtered and eight MSI-H no direct evidence of the extent of the field change around this tumours with positive BRAF mutation were selected for further group of tumours that can provide support for either theory, and testing. Paraffin-fixed slides from the tumour and the proximal hence, the adequacy of current resection margins is questionable. and distal margins were extracted from the database and used Current resection margin standards of a 5-cm margin proximal for testing. and distal to the tumour are derived from research on a separate Tumour blocks, adjacent non-tumour blocks and margin group of tumours arising from the chromosomal instability blocks were selected for analysis. Histological review was pathway (i.e. the FAP pathway). There is a need to exclude the performed to ensure the absence of histological evidence of a presence of a generalised field change and, if it is excluded, to tumour. Adjacent normal mucosa was defined as histologically determine the extent of the local field change in sporadic BRAF normal mucosa at a distance of at least 5 mm from the tumour. mutation-positive tumours. Each of the aforementioned formalin-fixed paraffin-embedded Mutation of the BRAF gene occurs early in the tumorigenesis (FFPE) blocks were divided into ten sections of 5 μm in thickness pathway leading to these two subgroups of colorectal cancers.(1-4,13) and deparaffinisation using standard xylene with the automated Using this knowledge as a foundation for this study, BRAF Ventana system was performed. DNA extraction was performed mutations can be used as a surrogate marker for detection of early using the Qiagen FFPE Kit and DNA concentration was assessed field change in apparently normal mucosa that can potentially lead using the Nanodrop analyser. Minimum DNA amounts of 300 ng to tumour formation in the future. The concept of field change, were required for BRAF analysis. BRAF mutational analysis was also known as field cancerisation, was first mooted in a study by performed using the Entrogen KRAS/BRAF Mutation Analysis Kit Slaughter et al in 1953.(14) Field change is described as a ‘process (v1.2). This kit uses allele-specific real-time polymerase chain whereby cells in a particular tissue or organ are transformed such reaction (PCR) and detects the V600E mutation of exon 15 of that genetically altered but histologically normal-appearing cells the BRAF gene. It may also detect some BRAF V600K mutations precede the development of neoplasia or coexist with malignant as V600E mutations. The BRAF V600E mutation accounts for a cells, irrespective of clonality’.(15) The essence of field change is the majority of BRAF mutations. The assay demonstrates a limit of existence of normal-looking cells or tissue that harbours genetic detection of up to 1% sensitivity. alterations predisposing them to overt malignant transformation. The presence of four MMR proteins, namely MLH1, MSH2, Multiple mechanisms of field change have been proposed,(16)
Recommended publications
  • Evidence for Field Effect Cancerization in Colorectal Cancer
    Genomics 103 (2014) 211–221 Contents lists available at ScienceDirect Genomics journal homepage: www.elsevier.com/locate/ygeno Evidence for field effect cancerization in colorectal cancer L. Hawthorn a,⁎,L.Lana, W. Mojica b a Cancer Center, Georgia Regents University, Augusta, GA, USA b Department of Pathology, Kalieda Health System, Buffalo, NY, USA article info abstract Article history: We compared transcript expression, and chromosomal changes on a series of tumors and surrounding tissues to Received 19 April 2013 determine if there is evidence of field cancerization in colorectal cancer. Epithelial cells were isolated from tu- Accepted 9 November 2013 mors and areas adjacent to the tumors ranging from 1 to 10 cm. Tumor abnormalities mirrored those previously Available online 4 December 2013 reported for colon cancer and while the number and size of the chromosomal abnormalities were greatly reduced in cells from surrounding regions, many chromosome abnormalities were discernable. Interestingly, these abnor- Keywords: malities were not consistent across the field in the same patient samples suggesting a field of chromosomal in- Field effect cancerization Colon cancer stability surrounding the tumor. A mutator phenotype has been proposed to account for this instability which Transcript expression states that the genotypes of cells within a tumor would not be identical, but would share at least a single mutation Chromosome copy number in any number of genes, or a selection of genes affecting a specific pathway which provide a proliferative LOH advantage. © 2013 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
    [Show full text]
  • Oral Field Cancerization
    image-mignogna_Layout 1 11-09-14 11:39 AM Page 1622 Practice CMAJ Clinical images Oral field cancerization Giulio Fortuna DMD PhD, Michele D. Mignogna MD DMD Competing interests: None declared. This article has been peer reviewed. Affiliations: From the Department of Dermatology (Fortuna), Program in Epithelial Biology, Stanford University School of Medicine, Stanford, Calif.; and the Oral Medicine Unit (Fortuna, Mignogna), Department of Odontostomatological and Maxillofacial Sciences, Federico II University of Naples, Naples, Italy Correspondence to: Prof. Michele D. Mignogna, [email protected] CMAJ 2011. DOI:10.1503 /cmaj.110172 Figure 1: Dorsum of the tongue of a 76-year-old man with a history of smoking, showing multiple lesions on the left. Histologic examination from multiple oral biopsies showed features consistent with verrucous carcinoma (very low-grade squamous cell carcinoma) (black arrow), well-differentiated squamous cell carci - noma (white arrowhead), verrucous hyperplasia (black arrowhead), severe dysplasia and carcinoma in situ (circle), and hyperparakeratosis with acanthosis and without dysplasia (white arrows). 76-year-old man with chronic obstructive lesions. 2 Tobacco and alcohol use are independent lung disease and a 60 pack-year history of risk factors, but when combined, they have a syn - A smoking presented with diffuse lesions on ergistic effect. 3 Although the earliest lesions are his tongue that had been evolving for three years often undetectable by clinical and histologic (Figure 1 ). After multiple biopsies showing a examination, careful surveillance can detect most range of dysplasia, all lesions were surgically tumours in their intraepithelial and microinvasive removed. He has stopped smoking and, after four stage.
    [Show full text]
  • Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: a Multiscale Modeling Approach Marc D
    Published OnlineFirst October 20, 2016; DOI: 10.1158/0008-5472.CAN-16-1054 Cancer Integrated Systems and Technologies: Mathematical Oncology Research Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach Marc D. Ryser1, Walter T. Lee2,3, Neal E. Ready4, Kevin Z. Leder5, and Jasmine Foo6 Abstract High rates of local recurrence in tobacco-related head and dence of the local field size on age at diagnosis, with a doubling neck squamous cell carcinoma (HNSCC) are commonly attrib- of the expected field diameter between ages at diagnosis of 50 uted to unresected fields of precancerous tissue. Because they and 90 years, respectively. Similarly, the probability of harbor- are not easily detectable at the time of surgery without addi- ing multiple, clonally unrelated fieldsatthetimeofdiagnosis tional biopsies, there is a need for noninvasive methods to was found to increase substantially with patient age. On the predict the extent and dynamics of these fields. Here, we basis of these findings, we hypothesized a higher recurrence risk developed a spatial stochastic model of tobacco-related in older than in younger patients when treated by surgery alone; HNSCC at the tissue level and calibrated the model using a we successfully tested this hypothesis using age-stratified out- Bayesian framework and population-level incidence data from come data. Further clinical studies are needed to validate the the Surveillance, Epidemiology, and End Results (SEER) regis- model predictions in a patient-specific setting. This work high- try. Probabilistic model analyses were performed to predict the lights the importance of spatial structure in models of epithelial field geometry at time of diagnosis, and model predictions of carcinogenesis and suggests that patient age at diagnosis may be age-specific recurrence risks were tested against outcome data a critical predictor of the size and multiplicity of precancerous from SEER.
    [Show full text]
  • Reappraisal of the Field Effect Concept in Cancer Predisposition
    Modern Pathology (2015) 28, 14–29 14 & 2015 USCAP, Inc All rights reserved 0893-3952/15 $32.00 Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression Paul Lochhead1, Andrew T Chan2,3, Reiko Nishihara4,5, Charles S Fuchs3,4, Andrew H Beck6, Edward Giovannucci3,5,7 and Shuji Ogino4,7,8 1Gastrointestinal Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK; 2Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA; 3Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; 5Department of Nutrition, Harvard School of Public Health, Boston, MA, USA; 6Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; 7Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA and 8Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA The term ‘field effect’ (also known as field defect, field cancerization, or field carcinogenesis) has been used to describe a field of cellular and molecular alteration, which predisposes to the development of neoplasms within that territory. We explore an expanded, integrative concept, ‘etiologic field effect’, which asserts that various etiologic factors (the exposome including dietary, lifestyle, environmental, microbial, hormonal, and genetic factors) and their interactions (the interactome) contribute to a tissue microenvironmental milieu that constitutes a ‘field of susceptibility’ to neoplasia initiation, evolution, and progression. Importantly, etiological fields predate the acquisition of molecular aberrations commonly considered to indicate presence of filed effect.
    [Show full text]
  • Field Cancerization - a Surgeons Dilemma
    International Surgery Journal Mehta A et al. Int Surg J. 2014 Nov;1(3):152-154 http://www.ijsurgery.com pISSN 2349-3305 | eISSN 2349-2902 DOI: 10.5455/2349-2902.isj20141101 Case Report Eagles eye for exploration: Field cancerization - a surgeons dilemma Ashok Mehta1, Ritika Agrawal2* 1Medical Director & Consultant Cancer Surgeon, Brahma Kumaris’ Global Hospital and Research Centre Managing BSES Muncipal General Hospital, Mumbai, Maharashtra, India 2Department of Head and Neck Oncosurgery, Brahma Kumaris’ Global Hospital and Research Centre Managing BSES Muncipal General Hospital, Mumbai, Maharashtra, India Received: 13 August 2014 Accepted: 22 September 2014 *Correspondence: Dr. Ritika Agrawal, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT “Field cancerization” was introduced in 1953 to describe histologically abnormal tissues surrounding oral squamous cell carcinoma, particularly in the upper aerodigestive tract, likely related to exposure to carcinogens. Concept now refers to multiple local and distant primary tumors within the upper aerodigestive tract, along with oral premalignant lesions. Tobacco and alcohol are independent risk factors, but when combined, they have a synergistic effect. Earliest lesions are often undetectable by clinical and histologic examination; careful surveillance can detect most tumors in their intraepithelial and microinvasive stage. Early detection improves long-term survival, although multiple resections are often necessary. Keywords: Field cancerization, Micro invasive stage, Local and distant tumors INTRODUCTION and consequently were responsible for the occurrence of local tumor recurrences.
    [Show full text]
  • Download PDF Evidence Based Demonstration of the Concept Of
    Rom J Morphol Embryol 2015, 56(3):1027–1033 R J M E RIGINAL APER Romanian Journal of O P Morphology & Embryology http://www.rjme.ro/ Evidence based demonstration of the concept of ‘field cancerization’ by p53 expression in mirror image biopsies of patients with oral squamous cell carcinoma – an immunohistochemical study ALKA H. HANDE1), DEEPALI P. MOHITE2), MINAL S. CHAUDHARY1), MIMANSHA PATEL1), PRIYANKA AGARWAL1), SHRUTI BOHRA1) 1)Department of Oral Pathology and Microbiology, Sharad Pawar Dental College and Hospital, Datta Meghe Institute of Medical Sciences (DU), Sawangi (Meghe), Wardha, Maharashtra, India 2)Department of Oral Pathology and Microbiology, Swargiya Dadasaheb Kalmegh Smruti Dental College and Hospital, Hingna, Nagpur, Maharashtra, India Abstract Objective: The main rationale for treatment failure and death of the patients with oral squamous cell carcinoma (OSCC) is loco-regional recurrence, development of second primary tumor (SPT) and metastasis, which could be well explained by concept of field cancerization. Identification of patients at high risk for development of SPT is an important part of research for cancer management. This study was designed keeping this aspect in mind and utilizing the increased expression of p53 as an indicator of existence of altered fields in mirror image biopsies of OSCC patients. Design: Forty clinically diagnosed oral cancer patients were included in the study. Biopsy tissue samples from clinically diagnosed oral cancer patients (Group A) and the mirror image, clinically normal looking mucosa at corresponding contralateral anatomical site (Group B) were studied for histopathological evaluation and p53 immunoexpression. Results: Tissue alterations were observed in Groups A and B. There was statistically significant (chi-square value – 126.6, p=0.0001) difference in grades of epithelial dysplasia and p53 immunoexpression in Group B.
    [Show full text]
  • Contribution to Characterization of Skin Field Cancerization Activity
    An Bras Dermatol. 2019;94(6):698---703 Anais Brasileiros de Dermatologia www.anaisdedermatologia.org.br INVESTIGATION Contribution to characterization of skin field cancerization activity: morphometric, chromatin ଝ,ଝଝ texture, proliferation, and apoptosis aspects a,b,∗ c Anna Carolina Miola , Mariana Anteghini Castilho , a d Juliano Vilaverde Schmitt , Mariangela Esther Alencar Marques , a Helio Amante Miot a Department of Dermatology and Radiotherapy, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil b Department of Dermatology, Instituto Lauro de Souza Lima, Bauru, SP, Brazil c Discipline of Radiology and Diagnostic Imaging, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil d Department of Pathology, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil Received 26 January 2019; accepted 22 March 2019 Available online 25 October 2019 Abstract KEYWORDS Background: A skin field cancerization is a cutaneous area with subclinical changes resultant Carcinoma, squamous from chronic sun exposure, with a higher predisposition to development of pre-neoplastic and cell; neoplastic lesions. So far, there are no well-defined objective parameters that can indicate Keratosis, actinic; their degree of activity. Skin neoplasms Objectives: To describe and compare morphometric aspects and expression of factors related to apoptosis and cell proliferation in actinic keratosis (AK), in both photoexposed and photo- protected epidermis. Methods: A cross-sectional study of patients with actinic keratosis in the forearms, biopsied at two points: the actinic keratosis and the axillary region. The biopsies of the actinic kerato- sis, perilesional area, and axilla were evaluated through keratinocyte intraepithelial neoplasia (KIN), and immunohistochemistry of p53, survivin, and Ki67.
    [Show full text]
  • Field of Cancerization:" Establishing New Paradigms for the Patient at Risk for Lung Cancer
    Published OnlineFirst December 11, 2012; DOI: 10.1158/1940-6207.CAPR-12-0470 Cancer Prevention Perspective Research See related article by Kadara et al., p. 8 Enriching the Molecular Definition of the Airway "Field of Cancerization:" Establishing New Paradigms for the Patient at Risk for Lung Cancer Brigitte N. Gomperts1,2,5,6, Tonya C. Walser2,6, Avrum Spira7,8,9, and Steven M. Dubinett2,3,4,6,10 Abstract The "field of cancerization" refers to histologically normal-appearing tissue adjacent to neoplastic tissue that displays molecular abnormalities, some ofwhicharethesameasthoseofthetumor.Improv- ing our understanding of these molecular events is likely to increase our understanding of carcinogen- esis. Kadara and colleagues attempt to characterize the molecular events occurring temporally and spatially within the field of cancerization of patients with early-stage non–small cell lung cancer (NSCLC) following definitive surgery. They followed patients with bronchoscopies annually after tumor resection and extracted RNA from the serial brushings from different endobronchial sites. They then conducted microarray analysis to identify gene expression differences over time and in different sites in the airway. Candidate genes were found that may have biologic relevance to the field of cancerization. For example, expression of phosphorylated AKT and ERK1/2 was found to increase in the airway epithelium with time. Although there are limitations in the study design, this investigation demonstrates the utility of identifying molecular changes in histologically normal airway epithelium in lung cancer. In addition to increasing our understandingoflungcancerbiology, studying the field of cancerization has the potential to identify biomarkers from samples obtained in a minimally invasive manner.
    [Show full text]
  • Deficient Pms2, ERCC1, Ku86, Ccoi in Field Defects During Progression to Colon Cancer
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Journal of Visualized Experiments www.jove.com VideoArticle Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer Huy Nguyen1, Cristy Loustaunau1,Alexander Facista 1, Lois Ramsey1, Nadia Hassounah1, Hilary Taylor1, Robert Krouse2,3, Claire M. Payne1,4, V. Liana Tsikitis3, Steve Goldschmid5, Bhaskar Banerjee5, Rafael F. Perini5, Carol Bernstein1 1Department of Cell Biology andAnatomy, College of Medicine, University ofArizona, Tucson 2SouthernArizona VeteransAffairs Health Care System,Tucson, AZ 3Department of Surgery, College of Medicine, University ofArizona, Tucson 4Biomedical Diagnostics and Research,Tucson, AZ 5Department of Medicine, College of Medicine, University ofArizona, Tucson Correspondence to: Carol Bernstein at [email protected] URL: http://www.jove.com/details.php?id=1931 DOI: 10.3791/1931 Citation: Nguyen H., Loustaunau C., Facista A., Ramsey L., Hassounah N.,Taylor H., Krouse R., Payne C.M.,Tsikitis V.L., Goldschmid S., Banerjee B., Perini R.F., Bernstein C. (2010). Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer. JoVE. 41. http://www.jove.com/details.php?id=1931, doi: 10.3791/1931 Abstract In carcinogenesis, the "field defect" is recognized clinically because of the high propensity of survivors of certain cancers to develop other malignancies of the same tissue type, often in a nearby location. Such field defects have been indicated in colon cancer.The molecular abnormalities that are responsible for a field defect in the colon should be detectable at high frequency in the histologically normal tissue surrounding a colonic adenocarcinoma or surrounding an adenoma with advanced neoplasia (well on the way to a colon cancer), but at low frequency in the colonic mucosa from patients without colonic neoplasia.
    [Show full text]
  • Cancerization: Evidence and Clinical Implications
    A Genetic Explanation of Slaughter's Concept of Field Cancerization: Evidence and Clinical Implications Boudewijn J. M. Braakhuis, Maarten P. Tabor, J. Alain Kummer, et al. Cancer Res 2003;63:1727-1730. Updated version Access the most recent version of this article at: http://cancerres.aacrjournals.org/content/63/8/1727 Cited Articles This article cites by 42 articles, 14 of which you can access for free at: http://cancerres.aacrjournals.org/content/63/8/1727.full.html#ref-list-1 Citing articles This article has been cited by 72 HighWire-hosted articles. Access the articles at: http://cancerres.aacrjournals.org/content/63/8/1727.full.html#related-urls E-mail alerts Sign up to receive free email-alerts related to this article or journal. Reprints and To order reprints of this article or to subscribe to the journal, contact the AACR Publications Subscriptions Department at [email protected]. Permissions To request permission to re-use all or part of this article, contact the AACR Publications Department at [email protected]. Downloaded from cancerres.aacrjournals.org on February 18, 2014. © 2003 American Association for Cancer Research. [CANCER RESEARCH 63, 1727–1730, April 15, 2003] Perspectives in Cancer Research A Genetic Explanation of Slaughter’s Concept of Field Cancerization: Evidence and Clinical Implications1 Boudewijn J. M. Braakhuis,2 Maarten P. Tabor, J. Alain Kummer, C. Rene´Leemans, and Ruud H. Brakenhoff Departments of Otolaryngology/Head and Neck Surgery, Section Tumor Biology [B. J. M. B., M. P. T., C. R. L., R. H. B.] and Department of Pathology [J. A. K.], Oncology Research Institute, Vrije Universiteit Medical Center, P.
    [Show full text]
  • Review: Field Effect in Cancer–An Update
    Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol. 39, no. 4, 2009 331 Review: Field Effect in Cancer–An Update Hong Chai and Robert E. Brown Department of Pathology and Laboratory Medicine, University of Texas Health Science Center–Medical School at Houston, Houston, Texas Abstract. The concept “field effect in cancer” originated in 1953 from the histopathological observations of Slaughter and colleagues [1] regarding the occurrence of multiple primary oral squamous cell carcinomas and their local recurrences. The development of modern molecular technologies has extended the field effect concept by exploring the molecular abnormalities in tissues that appear histologically normal. To date, such field effect biomarkers have been reported in several sites and organs, eg, head and neck, colon and rectum, prostate, breast, lung, esophagus, stomach, and skin. Two popular hypotheses have been proposed. One hypothesis implicates genetic alterations that occur in a stepwise fashion (initiation, promotion, and progression); a clone gains growth advantage and acquires more genetic alterations, which eventually result in cancer. A second hypothesis focuses on epigenetic alterations, which include hypermethylation of the DNA promoter of certain tumor suppressor genes, leading to down-regulation of these genes. In this update, we discuss in detail the evidence that supports these two hypotheses. In addition, we attempt to provide a comprehensive overview of the field effect in carcinogenesis and its possible mechanisms in various organs. Moreover, we discuss the potential utilization of field effect biomarkers in cancer prevention, surgical considerations, and clinical prognosis. Keywords: field effect, carcinogenesis, field cancerization, multiple primary cancers, DNA methylation Introduction benign contiguous tissue.
    [Show full text]
  • Field Cancerization in Head and Neck Squamous Cell
    ISSN 1807-5274 Rev. Clín. Pesq. Odontol., Curitiba, v. 6, n. 1, p. 17-27, jan./abr. 2010 Licenciado sob uma Licença Creative Commons FIELD CANCERIZATION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: immunohistochemical expression of p53 and Ki67 proteins: clinicopathological study TÍTULO Cancerização por campo em carcinoma de células escamosas: expressão imuno-histoquímica de proteínas p53 e Ki67: estudo clínico-patológico Marcos Vinício Macedo de Oliveira [a] , Carlos Alberto de Carvalho Fraga [a] , Camila Santos Pereira [a] , Lucas Oliveira Barros [a] , Erica Silva Oliveira [a] , André Luiz Sena Guimarães [b] , Alfredo Maurício Batista de Paula [b] [a] Undergraduate students, Department of Biological Sciences, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, MG - Brazil, e-mail: [email protected] [b] DDS, PhD, Department of Dentistry, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, MG - Brazil. Abstract OBJECTIVE : This study is aimed to evaluate the immunostaining influence of p53 and Ki67 proteins in areas of field cancerization of head and neck squamous cell carcinoma (HNSCC). We analyzed associations of these proteins with clinicopathological parameters and the relation between their immunoexpression in HNSCC. MATERIAL AND METHOD : In a retrospecive analysis, 40 patients with HNSCC were selected according to the recurrence of the disease, forming two groups: recurrent and non-recurrent HNSCC. Morphological gradations and imunnohistochemical analysis of p53 and Ki67 were performed in invasive front and tumor adjacent epithelium. RESULTS : It was found significant associations between tumor recurrence and p53 positivity in mucosa and invasive front. However, no association was found between p53 immunostaining and the clinicopathological parameters. Ki67 was not related to any clinicopathological parameter either.
    [Show full text]